Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials | Journal for ImmunoTherapy of Cancer
Understanding Survival Analysis in Clinical Trials - Clinical Oncology
The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer | BMC Cancer | Full Text
Pancancer survival analysis of cancer hallmark genes | Scientific Reports
SOLO-2: Overall Survival Data on Olaparib for Relapsed, BRCA-Mutated Ovarian Cancer
Overall survival (OS) curves in each gastric cancer (GC) pathological... | Download Scientific Diagram
Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status | Journal for ImmunoTherapy of Cancer
Diagnostics | Free Full-Text | Prognostic Factors Associated with 5-Year Overall Survival in Cervical Cancer Patients Treated with Radical Hysterectomy Followed by Adjuvant Concurrent Chemoradiation Therapy at a Tertiary Care Center in
Prognostic factors in epithelial ovarian cancer: A population-based study | PLOS ONE
Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis - Katrin M. Sjoquist, Sarah J. Lord, Michael L. Friedlander, Robert John Simes, Ian C. Marschner,
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
The role of censoring on progression free survival: Oncologist discretion advised - ScienceDirect
Kaplan-Meier curves for overall survival (A) and progression-free... | Download Scientific Diagram
Retrospective observational cohort study on innovation in oncology and progress in survival: How far have we gotten in the two decades of treating patients with advanced non-small cell lung cancer as a
Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis | Scientific Reports
Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis | PLOS ONE
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer | NEJM
Kaplan-Meier curve of progression-free survival (PFS) (a) and overall... | Download Scientific Diagram
Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis | Radiation Oncology | Full Text
Oncotarget: Melatonin increases overall survi | EurekAlert!
Adjuvant chemotherapy improves overall survival in patients with stage IB non-small cell lung cancer
Breast Cancer Survival Rates: Prognosis by Age, Race & More
Overall survival (OS) in patients with metastatic breast cancer... | Download Scientific Diagram
